Loading...
Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis
- Ticker
- FDC.NSE
- Price
- 376.65
- Stock movement up
- +1.35 (0.36%)
- Company name
- FDC Limited
- Exchange
- (NSE ,
- Currency
- INR )
- Sector
- Healthcare >Drug Manufacturers - Specialty & Generic
- Market cap
- 61.32B
- Ent value
- -
- Price/Sales
- 2.95
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- 59.02%
- Trailing P/E
- 28.30
- Forward P/E
- -
- PEG
- -
- EPS growth
- 3.33%
- 1 year return (CAGR)
- -22.21%
- 3 year return (CAGR)
- 11.39%
- 5 year return (CAGR)
- 2.61%
- 10 year return (CAGR)
- 5.07%
Last updated: 2026-03-13
DIVIDENDS
FDC.NSE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | 28.30 |
| Price to OCF | 19.43 |
| Price to FCF | 44.61 |
| Price to EBITDA | 16.31 |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 2.95 |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 162.81M |
| EPS (TTM) | 13.31 |
| FCF per share (TTM) | 8.44 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 20.78B |
| Gross profit (TTM) | 11.39B |
| Operating income (TTM) | 2.20B |
| Net income (TTM) | 2.17B |
| EPS (TTM) | 13.31 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | 54.83% |
| Operating margin (TTM) | 10.59% |
| Profit margin (TTM) | 10.43% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 0.00 |
| Total current assets | 0.00 |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 0.00 |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 0.00 |
| Total liabilities | 0.00 |
| Shareholder's equity | 0.00 |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | 3.16B |
| Capital expenditures (TTM) | 1.78B |
| Free cash flow (TTM) | 1.37B |
| Dividends paid (TTM) | 811.34M |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 376.50 |
| Daily high | 381.65 |
| Daily low | 375.10 |
| Daily Volume | 73K |
| All-time high | 612.65 |
| 1y analyst estimate | 350.00 |
| Beta | -0.04 |
| EPS (TTM) | 13.31 |
| Dividend per share | 0.00 |
| Ex-div date | 11 Feb 2026 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| FDC.NSE | S&P500 | |
| Current price drop from All-time high | -38.52% | -0.89% |
| Highest price drop | -91.12% | -56.47% |
| Date of highest drop | 28 Oct 2002 | 9 Mar 2009 |
| Avg drop from high | -39.43% | -10.84% |
| Avg time to new high | 63 days | 12 days |
| Max time to new high | 3024 days | 1805 days |
COMPANY DETAILS
Marketcap
61.32B
Marketcap category
Large-cap
Description
FDC Limited, together with its subsidiaries, manufactures and trades in pharmaceutical products in India, the United States, and internationally. The company offers pharmaceutical formulations for various therapeutic segments, including anti-infectives, gastrointestinal, ophthalmology, vitamins, minerals, dietary supplements, cardiovascular and anti-diabetic therapies, respiratory care, gynaecology, dermatology, and analgesics in the form of tablets, capsules, oral liquids, ophthalmic drops, topical preparations, and paediatric-friendly solutions. It also provides functional food, such as flavoured ORS powders, ready-to-drink electrolyte beverages, vitamin-enriched supplements, antioxidant blends and protein-fortified drinks; and various active pharmaceutical ingredients. The company sells its products under the Zifi, Zefu, Zocon, Amodep-AT, Zathrin, Vitcofol, Ziglim, Ziglim-M,Mycoderm, Zoxan, Cotaryl, Pyrimon DF, Zipod, Electral, and Enerzal brands. It also exports its products to approximately 50 countries. FDC Limited was founded in 1936 and is based in Mumbai, India.
Employees
6857
Website
Investor relations
-
SEC filings
CEO
Country
India
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found